Julius Baer Group nominates Gilbert Achermann and Andreas Amschwand for Board of Directors
Gilbert Achermann has been instrumental in establishing the Straumann Group as global market leader in the implant dentistry industry. After ten years at UBS, he joined the company in 1998 as Chief Financial Officer and Deputy CEO. In 2002, he became President & Chief Executive Officer of Straumann, subsequently changing to its Board of Directors as Chairman in 2010. Furthermore, Gilbert Achermann has this year been appointed Chairman of the Board of Directors of the pharmaceutical company Siegfried Group.
Andreas Amschwand gained extensive banking expertise during his career at UBS. For many years he led the Foreign Exchange and Money Market department. In addition, he headed Investment Banking in Switzerland. Until February 2011, he managed the area Investment Products and Services and was Member of the Wealth Management Executive Committee. Andreas Amschwand was also member of the Boards of Directors of the SIS Swiss Financial Services Group and the SWX Swiss Exchange.
Independent management consultant Peter Kuepfer has been a member of Julius Baer’s Board of Directors since 1999, most recently chairing the Board’s Compensation and Nomination Committees. He also holds the position of the Independent Lead Director and was member of the Chairman’s and Risk Committee for a long time. During an eventful period, he has substantially contributed to the excellent financial and operational oversight and compliance of the Group.
“On behalf of the Board of Directors I sincerely thank Peter Kuepfer for his outstanding services to Julius Baer. In all those years, his prudent advice and great experience have been invaluable. Going forward, I am very pleased that we have been able to nominate Gilbert Achermann and Andreas Amschwand, two highly respected individuals whose vast know-how will further strengthen the already broad financial expertise of our Board,” commented Raymond J. Baer, Chairman of the Board.